Navigation Links
Cell Press announces new partnership with the Biophysical Society
Date:3/5/2008

CAMBRIDGE, Massachusetts (March 5, 2008) -- Cell Press has been chosen by The Biophysical Society to publish its premier semi-monthly journal from January 2009. The Biophysical Society and Cell Press anticipate tremendous synergies between Biophysical Journal content and that of the Cell Press journals, including Cell, Neuron, Molecular Cell, Current Biology, and Structure.

For more than 50 years the Biophysical Society has promoted the development and publication of knowledge in biophysics. It has done so by publicizing, encouraging, and strengthening research in the discipline, by supporting the career development of its members and by displaying and disseminating their work at its Annual Meeting and through its Journal, by its proactive lobbying in support of funding for all basic research, and by taking a strong stance on public service, responsibility and outreach activities. The Society's members, now about 8,000 in number, work in academia, industry, and in government agencies throughout the world. In considering the importance of this new partnership for the Biophysical Society, its new President, Harel Weinstein emphasizes that: The Biophysical Societys Council approved this development unanimously because it will help us strengthen the core missions of the Society by expanding the readership and visibility of Biophysical Journal, and thereby increase the dissemination and the impact on society at large of the exciting results from research in biophysics, one of the main growth areas in science.

I am very pleased to welcome Biophysical Journal as a great complement to Cell Press content and mission, said Lynne Herndon, President and CEO of Cell Press.

By partnering with the Biophysical Society, Cell Press further strengthens its commitment to fostering scientific communication through the publication of exciting original research. Cell Press is recognized for its close relationship with the scientific community and for consi
'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Learning how to say no to alcohol advertising and peer pressure works for inner-city adolescents
2. Drinking milk may help ease the pressure
3. Immunosuppressant further linked to birth defects
4. Why serotonin can cause depression and anxiety
5. American Chemical Societys Weekly PressPac -- Jan. 16, 2008
6. MNI researchers locate neurological basis of depression following sports concussion
7. Humana Press journals now available on SpringerLink
8. American Chemical Societys weekly PressPac -- Jan. 9, 2008
9. Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic
10. High blood pressure in older adults traced to genes effects in blood vessels
11. American Chemical Societys weekly PressPac -- Jan. 2, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...peful news is that pediatric survival rates have s...eatments that enable survival often cause infertil...ched puberty currently have an opportunity to pres...atment, they may have their semen frozen and prese... produce sperm, although their testicular tissue c...
(Date:11/9/2009)...Energy (DOE) has announced plans to fund research ...chool of Engineering on technologies that would he...ture and permanent safe storage, or sequestration,...oration with Southern Company, the parent company ...e 2009 American Recovery and Reinvestment Act, the...
(Date:11/9/2009)...is publishing a special issue "Beyond the Origin: ...Darwin,s On the Origin of Species which was publis...nd author of the lead article is Dr. Ulrich Kutsch...y biology at the University of Kassel in Germany. ...ree of charge until 30 December 2009 on Springer,s...
Breaking Biology News(10 mins):For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2009 Financial Results 5193 1Growing greener greens 10244 1Growing greener greens 10244 2Growing greener greens 10244 3Drug May Help Colitis Patients Avoid Surgery 58775 1
...es of shepherds and travellers encountering lions,...tales about attacks on flocks and people by these ...most of their former range, but for livestock owne... with lions is a daily reality. Although loss of h...ost the herders close to 1000 US$ per family each ...
...was launched today by the Chinese National Space A...e Xichang Satellite Launch Centre, Sichuan, atop a...first step in the Chinese ambition to land robotic... four mission goals to accomplish. The first is to...orms and outline maps of major lunar geological st...
... Germany-October 24, 2007-Harvard University,s Off... announced an agreement to jointly establish the B...at Harvard,s School of Engineering and Applied Sci...ng strong ties with departments and schools throug...ative, integrated partnership among Harvard and BA...
Other Biology News:Living with lions 2Chang'e-1 -- new mission to Moon lifts off 2BASF and Harvard University announce extensive research collaboration 2
(Date:11/6/2009)...-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NA...nnounced updated results from a Phase II study of ...metastatic to the lung in a poster presentation at...y Meeting held in Miami Beach, Florida, from Novem..."A Phase II Study of Intravenous REOLYSIN (Wild-ty...
(Date:11/6/2009)...nda for Arrowhead’s 2010 Personalized Medici...lace on February 22-24, 2010 in Philadelphia, has ...ll highlight key issues in forming partnerships an...ces. , Minneapolis, MN (P...’s 2010 Personalized Medicine Partnerships ...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
(Date:11/5/2009)...RNewswire/ -- DSM Pharmaceutical Products today an...with Galenix, Saint Jean D,Illac, France, where DS...ring partner for Galenix commercial products on a ...te on business development opportunities co-market...he strength of Galenix in drug product development...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...ION CITY, Calif., June 2 Santen,Pharmaceutical Co...he two,companies have entered into a research and ...r the Japanese and Asian development and,commercia...diseases and,conditions including wet age related ...r edema (DME). Sirolimus, originally known as rapa...
...tic mutations that can affect patient response to ...EASANTON, Calif., June 2 Roche and DxS Ltd. have,... DxS TheraScreen K-RAS,Mutation Test and TheraScre...when considered with other clinically relevant fac...nts likely to benefit from a specific,cancer thera...
... the 44th Annual Meeting of,the American Society o...nted investigating the potential utility of Zevali...replacement for external beam radiations or,supple... non-Hodgkin,s,lymphoma (NHL). Cell Therapeutics, ...n the United States., "These two studies add to t...
Other Biology Technology:Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions 2Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions 3Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests 2Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests 3Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 2Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 3Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 4
Custom Production Service - Quality from AbD Serotec
Rat Big Endothelin-1 (Big ET-1) EIA Kit from Assay Designs/Stressgen Bioreagents
...ptide Synthesis , 20 Amino Acid length max , MS... to customer for future usage conjugation of pepti... 102 days/each , Pre-immune bleed x1 /each , ...t bleed (app. 5 ml) x1 /each , Production blee...
Mouse Anti-Mouse Qa-1 Monoclonal Antibody, Unconjugated, Clone 6A8.6F10 from Santa Cruz Biotechnology, Inc.
Biology Products: